The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $79.79

Today's change-0.92 -1.14%
Updated September 29 3:51 PM EDT. Delayed by at least 15 minutes.
 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $79.79

Today's change-0.92 -1.14%
Updated September 29 3:51 PM EDT. Delayed by at least 15 minutes.

Eli Lilly and Co crosses below 50-day moving average

Eli Lilly and Co closed lower Thursday, dropping (U.S.)$0.92 or 1.14% to (U.S.)$79.79 and crossing below its 50-day moving average. Over the last five days, shares have lost 1.85% and are down 5.31% for the last year to date. This security has underperformed the S&P 500 by 14.98% during the last year.

Key company metrics

  • Open(U.S.) $80.35
  • Previous close(U.S.) $80.71
  • High(U.S.) $80.47
  • Low(U.S.) $79.23
  • Bid / Ask(U.S.) $79.79 / (U.S.) $79.80
  • YTD % change-5.31%
  • Volume2,763,988
  • Average volume (10-day)3,553,455
  • Average volume (1-month)3,342,865
  • Average volume (3-month)3,779,436
  • 52-week range(U.S.) $67.88 to (U.S.) $88.48
  • Beta0.19
  • Trailing P/E34.39×
  • P/E 1 year forward22.50×
  • Forward PEG1.72×
  • Indicated annual dividend(U.S.) $2.04
  • Dividend yield2.56%
  • Trailing EPS(U.S.) $2.32
Updated September 29 3:51 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.21%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue5,4054,8655,3764,960
Total other revenue--------
Total revenue5,4054,8655,3764,960
Gross profit3,9403,5423,9863,723
Total cost of revenue1,4651,3231,3891,237
Total operating expense4,4824,1494,9763,998
Selling / general / administrative1,6231,4741,7981,576
Research & development1,3361,2211,4441,143
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)5813134442
Other operating expenses, total--------
Operating income923716400961
Interest income (expense), net non-operating-57-57-57-55
Gain (loss) on sale of assets--------
Other--------
Income before tax9455674451,048
Income after tax748440478800
Income tax, total197127-34248
Net income748440478800
Total adjustments to net income--------
Net income before extra. items748440478800
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items748440478800
Inc. avail. to common incl. extra. items748440478800
Diluted net income748440478800
Dilution adjustment--------
Diluted weighted average shares1,0601,0631,0631,065
Diluted EPS excluding extraordinary itemsvalue per share0.710.410.450.75
Dividends per sharevalue per share0.510.510.600.50
Diluted normalized EPSvalue per share0.750.510.730.78